Spectrascience New Company Insiders
Spectrascience New employs about 5 people. The company is managed by 2 executives with a total tenure of roughly 22 years, averaging almost 11.0 years of service per executive, having 2.5 employees per reported executive. Evaluation of Spectrascience New's management performance can provide insight into the firm performance.
Michael Oliver CEO CEO and President COO and Director |
Spectrascience |
Spectrascience New Management Team Effectiveness
The company has return on total asset (ROA) of (0.9247) % which means that it has lost $0.9247 on every $100 spent on assets. This is way below average. Spectrascience New's management efficiency ratios could be used to measure how well Spectrascience New manages its routine affairs as well as how well it operates its assets and liabilities. At present, Spectrascience New's Return On Equity is projected to slightly decrease based on the last few years of reporting. At present, Spectrascience New's Total Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 5.10, whereas Other Assets are forecasted to decline to about 88.4 K.As of November 30, 2024, Net Loss is expected to decline to about (4.2 M)
Spectrascience New Workforce Comparison
Spectrascience New is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 90.0. Spectrascience New holds roughly 5.0 in number of employees claiming about 6% of equities under Health Care industry.
Spectrascience New Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Spectrascience New insiders, such as employees or executives, is commonly permitted as long as it does not rely on Spectrascience New's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Spectrascience New insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Miller Sheldon L over a month ago Acquisition by Miller Sheldon L of 100000 shares of Spectrascience New at 0.06 subject to Rule 16b-3 |
Spectrascience New Notable Stakeholders
A Spectrascience New stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Spectrascience New often face trade-offs trying to please all of them. Spectrascience New's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Spectrascience New's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael Oliver | CEO and President COO and Director | Profile | |
Lowell Giffhorn | CFO, Principal Accounting Officer and Secretary | Profile |
About Spectrascience New Management Performance
The success or failure of an entity such as Spectrascience New often depends on how effective the management is. Spectrascience New management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Spectrascience management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Spectrascience management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (14.20) | (13.49) | |
Return On Capital Employed | 0.23 | 0.25 | |
Return On Assets | (3.71) | (3.52) | |
Return On Equity | 0.38 | 0.40 |
Please note, the presentation of Spectrascience New's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Spectrascience New's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Spectrascience New's management manipulating its earnings.
Spectrascience New Workforce Analysis
Traditionally, organizations such as Spectrascience New use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Spectrascience New within its industry.Spectrascience New Manpower Efficiency
Return on Spectrascience New Manpower
Revenue Per Employee | 1K | |
Revenue Per Executive | 2.6K | |
Net Loss Per Employee | 893.3K | |
Net Loss Per Executive | 2.2M |
Complementary Tools for Spectrascience Stock analysis
When running Spectrascience New's price analysis, check to measure Spectrascience New's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectrascience New is operating at the current time. Most of Spectrascience New's value examination focuses on studying past and present price action to predict the probability of Spectrascience New's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectrascience New's price. Additionally, you may evaluate how the addition of Spectrascience New to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |